Office of Research and Development National Center for Computational Toxicology Amy Wang National Center for Computational Toxicology The views expressed.

Slides:



Advertisements
Similar presentations
Perspectives from EPA’s Endocrine Disruptor Screening Program
Advertisements

Dosimetry in Risk Assessment and a bit More Mel Andersen McKim Conference QSAR and Aquatic Toxicology & Risk Assessment June 27-29, 2006.
Office of Research and Development Computational Toxicology and High-Throughput Risk Assessment Richard Judson U.S. EPA, National Center for Computational.
UNEP Advisory Group Meeting Geneva, Switzerland December 12, 2014
Session III: Assessing Cumulative Effects of Endocrine Active Substances 9:15 - 9:30 Introduction” Rick Becker (Session Chair and Panel Moderator) 9:30.
MONITORING IN UNIVERSITY LABS PI: M. Ellenbecker (Toxics Use Reduction Institute) Post-doc: S. Tsai Funding from NSF EEC for the Nanoscale Science.
ONAMI’s - Safer Nanomaterials and Nanomanufacturing Initiative Recommendations for the FDA Nanotechnology Task Force Stacey Harper.
William H. Farland, Ph.D. Acting Deputy Assistant Administrator for Science Office of Research and Development U.S. ENVIRONMENTAL PROTECTION AGENCY Biomarkers:
Michael H. Dong MPH, DrPA, PhD readings Human Exposure Assessment II (8th of 10 Lectures on Toxicologic Epidemiology)
Office of Research and Development National Center for Computational Toxicology April 6, 2010 Exposure-Based Chemical Prioritization Workshop: Exploring.
Copyright 2002 Marc Rigas Issues in Exposure Assessment Marc L. Rigas, Ph.D. National Exposure Research Laboratory, U.S. Environmental Protection Agency.
What Do Toxicologists Do?
Discussion Our current results suggest that it is possible to identify susceptibility regions using this methodology. The presented method takes advantage.
The Tox21 Program Christopher P. Austin, M.D. Director, NIH Chemical Genomics Center The Future of Chemical Toxicity Testing in the U.S.: Creating a Roadmap.
IANH and ISO Proposals C. Michael Garner Garner Nanotechnology Solutions Visiting Scholar Stanford University EE Department.
Bioinformatics Ayesha M. Khan Spring Phylogenetic software PHYLIP l 2.
So many nanomaterials, so little understanding!
Carolyn J. Mattingly The Mount Desert Island Biological Laboratory Salisbury Cove, Maine The Comparative Toxicogenomics Database (CTD): Predicting mechanisms.
Assessing the Effects of Naphthenic Acids Using a Microbial Genome Wide Live Cell Reporter Array System Xiaowei Zhang 1,2 *, Steve Wiseman 2, Hongxia Yu.
Nanotechnology Summary. Potential Worker Exposures.
Chapter 13. The Impact of Genomics on Antimicrobial Drug Discovery and Toxicology CBBL - Young-sik Sohn-
Office of Research and Development National Center for Computational Toxicology Keith Houck, PhD ISRPT 2009 Endocrine Workshop 9-10 Sept 2009 What Can.
A PARADIGM ADVANCING TOXICITY TESTING OF NANOMATERIALS IN THE 21 st CENTURY AND QSAR MODELS DEVELOPMENT. David Y. Lai. U.S. EPA, Washington, DC. Feb. 9,
Betraying Paracelsus, Ignoring Newton: A Flaw in the Nanotoxicology Paradigm Justin Teeguarden, PHD, DABT [Paul Hinderliter, Joel Pounds, Brian Thrall,,
High Throughput Genotoxicity Profiling of the US EPA ToxCast TM Chemical Library S Little 1, AW Knight 2, L Birrell 2, G Akerman 3, N McCarroll 3, D Dix.
Kevin M. Crofton, PhD US Environmental Protection Agency McKim Conference Duluth MN September 17, 2008 Thyroid Mediated CNS Dysfunction How to use what.
The US Tox21 Collaboration: Advances Made and Lessons Learned
The CEINT Database Sandra Karcher Carnegie Mellon University / CEE To the Nanotechnology Working Group on September.
The Value of Tissue Banks to Drug and Dx Developers Barbara L. Handelin, Ph.D. Conflicts of Interest, Privacy/Confidentiality, and Tissue Repositories:
Computational biology of cancer cell pathways Modelling of cancer cell function and response to therapy.
Click to edit Master title style Click to edit Master text styles –Second level Third level –Fourth level »Fifth level Office of Research and Development.
THE NEED FOR NANOMATERIAL EVALUATION IN A PHYSIOLOGICALLY RELEVANT MODEL: CONNECTING ENVIRONMENTAL VARIABLES AND NM BEHAVIOR TO TOXICOLOGICAL RESPONSES.
RISK ASSESSMENT. Major Issues to be considered in designing the Study 1.- Emission Inventory What is the relative significance of the various sources.
CENTRE FOR BIOTECHNOLOGY
Cellular Toxicity of Carbon - based Nanomaterials Nano Letters, 2006, 6 (6), pp 1121–1125 Electrical Engineering and Computer Sciences University of California,
Biological Signal Detection for Protein Function Prediction Investigators: Yang Dai Prime Grant Support: NSF Problem Statement and Motivation Technical.
Pollution and Human Health
September 22, 2011 Office of Pollution Prevention and Toxics1.
Bioinformatics MEDC601 Lecture by Brad Windle Ph# Office: Massey Cancer Center, Goodwin Labs Room 319 Web site for lecture:
Key Research Questions: The University of Wisconsin – Madison Nanoscale Science and Engineering Center Social, Legal and Environmental Impacts of Engineered.
TOXICOGENOMICS.
UNDERSTANDING CHEMICAL ALLERGEN POTENCY THROUGH THE MOLECULAR EVENTS THAT TRIGGER IMMUNE CELL ACTIVATION Elena Kummer.
1 OSHA’s Approach to Nanotechnology: Developing a Searchable "Health Effects Matrix" Database for Nanomaterials Utilizing Existing Published Data Janet.
NER: Identifying & Regulating Environmental Impacts of Nanotechnology PI: N. Swami; Co-PI: M. Gorman; Students (Degree Program): A. Wardak (Ph.D.), E.
1 Nanoscale Materials Stewardship Program Environmental Summit May 20, 2008 Jim Alwood Chemical Control Division Office of Pollution Prevention and Toxics.
Office of Research and Development Photo image area measures 1.5” H x 7” and can be masked by a collage strip of one, two or three images. The photo image.
1 1 EPA Nanotechnology Research Program – LCA Considerations Jeff Morris National Program Director for Nanotechnology 5 November 2009.
The Future of Chemical Toxicity Testing in the U.S.
Perspective on the current state-of-knowledge of mode of action as it relates to the dose response assessment of cancer and noncancer toxicity Jennifer.
The effects of progesterone and synthetic derivatives on Fathead Minnow (Pimphales promelas) embryos. JA Stine and DB Huggett, Ph.D. Department of Biological.
Cytotoxic and Immunologic Effects of Silver Nanoparticles Shaun Cote.
Innovative Research for a Sustainable Future mg kg -1 d -1 * For more information please send to: AbstractOngoing.
Key Concepts on Health Risk Assessment of Chemical Mixtures.
Nanosafety ISO TC 229 Nanotechnologies Standardization in the field of nanotechnologies that includes either or both of the following:  1. Understanding.
Products > Transfection Reagent for BMS/BMS2 Cells (Bone Marrow Cells) Altogen Biosystems offers the BMS2 Transfection Reagent among a host of 100+ cell.
신기술 접목에 의한 신약개발의 발전전망과 전략 LGCI 생명과학 기술원. Confidential LGCI Life Science R&D 새 시대 – Post Genomic Era Genome count ‘The genomes of various species including.
전통적인 신약 개발 과정.
Products > Transfection Reagent for C6 Cells (Glioma Cells, CCL-107) Altogen Biosystems offers the C6 Transfection Reagent among a host of 100+ cell line.
Products > 3T3-L1 Transfection Reagent (Embryonic Fibroblast Cells, CL-173) Altogen Biosystems offers the 3T3-L1 Transfection Reagent among a host of 100+
Small Molecules that Enhance the Pharmacological Effects of Oligonucleotides Melissa Porter 1, Bing Yang 1, Canhong Cao 1, Xin Ming 1, Emily Hull-Ryde.
1 Risk Assessment for Air Toxics: The 4 Basic Steps NESCAUM Health Effects Workshop Bordentown, NJ July 30, 2008.
Who is NCCT? National Center for Computational Toxicology – part of EPA’s Office of Research and Development Research driven by EPA’s Chemical Safety for.
The Comparative Toxicogenomics Database (CTD):
The CompTox Chemistry Dashboard: an informational data hub at the
FIG. 1. Effect of BDCM on the organization of desmosomal proteins in trophoblast cultures. Cytotrophoblast cells were incubated with or without BDCM under.
OAK CREEK Toxicology & Risk Assessment Consulting
People Who Did the Study Universities they are affiliated with
Ovanes Mekenyan, Milen Todorov, Ksenia Gerova
Strategies for Integrated Human and Ecological Assessment
Presentation transcript:

Office of Research and Development National Center for Computational Toxicology Amy Wang National Center for Computational Toxicology The views expressed in this presentation are those of the author and do not necessarily reflect the views or policies of the U.S. Environmental Protection Agency. Mention of trade names or commercial products does not constitute endorsement or recommendation by EPA for use. Toward Predicting Nanomaterial Biological Effects -- ToxCast Nano Data as an Example

Office of Research and Development National Center for Computational Toxicology So many nanomaterials, so little understanding! 1 Over 2,800 pristine nanomaterials (NMs) 1 and numerous nanoproducts are already on the market. We have toxicity data for only a small number of them. Traditional mammalian tox testing for each NM is not practical. Estimated $249 million to $1.18 billion for NM already on the market in 2009 (Choi et al 2009) 1. Nanowerk. Nanomaterial Database Search. Available at: (Accessed July ) 2. Choi J-Y, Ramachandran G, Kandlikar M. The impact of toxicity testing costs on nanomaterial regulation. Environ Sci Technol 2009, 43:

Office of Research and Development National Center for Computational Toxicology ToxCast™ - Toxicity Forecaster Part of EPA’s computational toxicology research 2 () High-throughput screening (HTS)

Office of Research and Development National Center for Computational Toxicology High-throughput screening (HTS) and computational models may be able to help to Speed up screening and lower cost  Testing time in days. Can be <$0.5 per target per compound Prioritize research/hazard identification Characterize bioactivity Find correlation between NM physicochemical properties and bioactivity 3

Office of Research and Development National Center for Computational Toxicology NM testing in ToxCast Goals:  Identify key nanomaterial physico-chemical characteristics influencing its activities  Characterize biological pathway activity  Classify and prioritize NMs for further research/hazard identification 4 Profile Matching Physical chemical properties of NM >1000 chemicals; ~60 NMs (Ag, Au, TiO 2, SeO 2, ZnO, SiO 2, Cu, etc) HTS assay results ENPRA

Office of Research and Development National Center for Computational Toxicology Current nano data in ToxCast HTS of bioactivity completed for 70 samples (62 unique samples)  6 to 10 concentrations  Data are being analyzed Characterization of NM physicochemical properties in progress 5

Office of Research and Development National Center for Computational Toxicology Characterization data coverage 6

Office of Research and Development National Center for Computational Toxicology Determine testing conc. in cells Reported potential occupational inhalation exposure Estimated lung retention 7 Conc. (ug/cm 2 ) ♦ Testing concentration █ MPPD predicted lung retention of NM after 45 year exposure Gangwal et al. Environ Health Perspect 2011 Nov;119(11):

Office of Research and Development National Center for Computational Toxicology DNA Transcription factor activation (Attagene) RNA Protein expression profile (BioSeek) Protein Cell growth kinetics (ACEA Bioscience) Toxicity phenotype effects (Apredica) Developmental malformation (EPA) Function/ Phenotype HTS bioactivity coverage (1) 8

Office of Research and Development National Center for Computational Toxicology 9 After Nanomaterial Exposure Perform HTS Selected endpoints  Developmental effects in zebrafish embryos  Effects on transcription factors in human cell lines (Attagene)  Human cell growth kinetics (ACEA Biosciences)  Protein expression profiles in complex primary human cell culture models (BioSeek) (BioSeek/Asterand)  Toxicity phenotype effects (DNA, mitochondria, lysosomes etc.) in human and rat liver cells through high-content screening/ fluorescent imaging (Cellumen/Apredica) Primary human cell lines (co-culture) Pathways affected/ Mechanisms BioSeek/AsterandCellumen/Appredica ACEA Biosciences Attagene

Office of Research and Development National Center for Computational Toxicology Cells used in the HTS 10

Office of Research and Development National Center for Computational Toxicology DNA RNA Protein Function/ Phenotype HTS bioactivity coverage (2) 11 Transcription factor activation, 48 endpoints (Attagene) Total > 266

Office of Research and Development National Center for Computational Toxicology Bioactivity endpoints related to genes 12 Transcription factor activation (Attagene) Protein expression profile (BioSeek) Toxicity phenotype (Apredica)

Office of Research and Development National Center for Computational Toxicology Endpoints not mapped to genes 13 Cytotoxity in various assays Cell growth kinetics (ACEA) Toxicity phenotype: lysosomal mass, apoptosis, DNA texture, ER stress/DNA damage, steatosis, etc. (Apredica)

Office of Research and Development National Center for Computational Toxicology Calculated LEC and AC50 from dose-response curve 14 AC50 LEC Emax

Office of Research and Development National Center for Computational Toxicology Data are standardized and stored in EPA internal database - ToxCastDB 15 AC50 LEC Emax

Office of Research and Development National Center for Computational Toxicology PRELIMINARY results 16 high promiscuity was coupled with high potency

Office of Research and Development National Center for Computational Toxicology Strengths in our data set Consistent handling protocol, including dispersion/stock preparation Testing concentrations related to exposure condition, and each assay has >= 6 conc. to generate a dose-response curve HTS provides extensive coverage in bioactivities Good characterization coverage, including as received materials, in stock and testing mediums 17

Office of Research and Development National Center for Computational Toxicology Acknowledgments EPA National Center for Computational Toxicology  Keith Houck  Samantha Frady  Elaine Cohen Hubal  James Rabinowitz  David Dix  Bob Kavlock  Woodrow Setzer  ToxCast team National Center for Environmental Assessment  Mike Davis (J Michael Davis)  Jim Brown  Christy Powers National Health and Environmental Effects Research Laboratory Stephanie Padilla Will Boyes Carl Blackman  National Risk Management Research Laboratory Thabet Tolaymat Amro El Badawy Duke University, Center for the Environmental Implications of NanoTechnology (CEINT) Stella Marinakos Appala Raju Badireddy Mark Wiesner Mariah Arnold Richard Di Giulio Baylor University Cole Matson University of Massachusetts Lowell Gene Rogers ENPRA Lang Tran Keld Astrup Jensen OECD Christoph Klein Xanofi Inc Sumit Gangwal 18